Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Membrane metallo-endopeptidase-like 1 (MMEL1) is a member of the neutral endopeptidase (NEP) or membrane metallo-endopeptidase (MME) family. It is a type II transmembrane protein that may also exist in a secreted form, and is mainly expressed in testis, with limited expression in brain, kidney, and heart. MMEL1 acts as a metalloprotease involved in sperm function, potentially by modulating the processes of fertilization and early embryonic development. The broader NEP family, to which MMEL1 belongs, is implicated in pain perception, arterial pressure regulation, phosphate metabolism, and homeostasis[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane metallo-endopeptidase-like 1 (MMEL1).